Author: KYIAS

Response comes in the aftermath of the Dr Bawa-Garba ruling Related items from OnMedica Bawa-Garba case: was the GMC biased? Confidence intervals Is the legal bar for convicting HCPs of manslaughter ‘too low’? Don’t increase sentences for medical manslaughter, urges MDU Rapid review ordered into medical manslaughter laws

Source: OnMedica

BMA welcomes decision to drop deportation case Related items from OnMedica Plans afoot for single route onto medical register MPs slam government over its Brexit immigration plans Big rise in overseas doctors wanting to work in UK New visa rules could prompt exodus of hundreds of doctors, warns BMA NHS ‘workforce gap’ is harming the quality of care

Source: OnMedica

Cancer Research UK in trans-Atlantic alliance Related items from OnMedica One-stop shops ‘will speed cancer diagnosis’ Prime minister announces £75 million to fund prostate cancer research Suspect cancer if patient has unexpected weight loss Cancer Alliances Only half of new cancer drugs extend or improve life

Source: OnMedica

(Reuters Health) – Most people have inaccurate beliefs about what cancer screening tests can do and what they cannot, suggests a recent study from the U.S. National Cancer Institute.

Source: Reuters Medical News

LONDON (Reuters) – British Prime Minister Theresa May will pledge cash to help improve children’s education in the Commonwealth and call for a commitment from fellow leaders to tackle malaria on Tuesday.

Source: Reuters Medical News

(Reuters) – Shares of U.S. drug suppliers rose on Monday after a report that Amazon.com Inc had dropped plans to sell drugs to hospitals, in a boost to a pharmaceutical supply chain rattled by the looming threat of competition from the online retailer.

Source: Reuters Medical News

MEXICO CITY (Reuters) – The head of the International Coffee Organization criticized a U.S. judge’s decision requiring cancer warnings on coffee sold in California by Starbucks and other retailers, expressing concern that the push for cancer labels may spread.

Source: Reuters Medical News

LONDON (Reuters) – Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion.

Source: Reuters Medical News

SAN FRANCISCO (Reuters) – Google told Reuters Monday it would resume accepting ads from U.S. addiction treatment centers in July, nearly a year after the Alphabet Inc unit suspended the lucrative category of advertisers for numerous deceptive and misleading ads.

Source: Reuters Medical News

(Reuters) – Merck & Co’s immunotherapy Keytruda plus chemotherapy significantly improved overall survival in newly-diagnosed patients with advanced non-small cell lung cancer in a closely-watched study, cementing its lead position over Bristol-Myers Squibb Co and others in the most lucrative oncology market.

Source: Reuters Medical News